Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening

Gynecologic Oncology

Volumn 103, Issue 1, 2006, Pages 62-66

  Ekalaksananan, Tipaya ^a   Pientong, Chamsai ^a   Sriamporn, Supannee ^a   Kongyingyoes, Bunkerd ^a   Pengsa, Prasit ^a   Kleebkaow, Pilaiwan ^a   Kritpetcharat, Onanong ^a   Parkin, D Max ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Combining test; HPV; p16 protein

Indexed keywords

PROTEIN P16;

ADULT; ARTICLE; CANCER SCREENING; COLPOSCOPY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL METAPLASIA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS DETECTION; WART VIRUS;

ADULT; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33748542684     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.01.033     Document Type: Article

References (38)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. Baseman J.G., and Koutsky L.A. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32 Suppl. 1 (2005) S16-S24
3. Fahey M.T., Irwig L., and Macaskill P. Meta-analysis of Pap test accuracy. Am. J. Epidemiol. 141 (1995) 680-689
4. Nanda K., McCrory D.C., Myers E.R., et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann. Intern. Med. 132 (2000) 810-819
5. Klinkhamer P.J., Meerding W.J., Rosier P.F., and Hanselaar A.G. Liquid-based cervical cytology. Cancer 99 (2003) 263-271
6. Franco E.L. Chapter 13: primary screening of cervical cancer with human papillomavirus tests. J. Natl. Cancer Inst. Monogr. (2003) 89-96
7. Lorincz A.T., and Richart R.M. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch. Pathol. Lab. Med. 127 (2003) 959-968
8. Wright Jr. T.C., Schiffman M., Solomon D., et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet. Gynecol. 103 (2004) 304-309
9. Kjaer S.K., van den Brule A.J., Paull G., et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325 (2002) 572
10. Ho G.Y., Bierman R., Beardsley L., Chang C.J., and Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338 (1998) 423-428
11. Moscicki A.B. Cervical cytology screening in teens. Curr. Womens Health Rep. 3 (2003) 433-437
12. Monsonego J., Bosch F.X., Coursaget P., et al. Cervical cancer control, priorities and new directions. Int. J. Cancer 108 (2004) 329-333
13. Nakao Y., Yang X., Yokoyama M., et al. Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br. J. Cancer 75 (1997) 1410-1416
14. Khleif S.N., DeGregori J., Yee C.L., et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 4350-4354
15. Sano T., Oyama T., Kashiwabara K., Fukuda T., and Nakajima T. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol. Int. 48 (1998) 580-585
16. Hawley-Nelson P., Vousden K.H., Hubbert N.L., Lowy D.R., and Schiller J.T. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8 (1989) 3905-3910
17. Klaes R., Friedrich T., Spitkovsky D., et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 92 (2001) 276-284
18. Murphy N., Ring M., Killalea A.G., et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J. Clin. Pathol. 56 (2003) 56-63
19. Sano T., Masuda N., Oyama T., and Nakajima T. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol. Int. 52 (2002) 375-383
20. Sriamporn S., Parkin D.M., Pisani P., et al. A prospective study of diet, lifestyle, and genetic factors and the risk of cancer in Khon Kaen province, northeast Thailand: description of the cohort. Asian Pac. J. Cancer Prev. 6 (2005) 295-303
21. Pientong C., Ekalaksananan T., Kongyingyoes B., et al. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection. Diagn. Cytopathol. 31 (2004) 235-242
22. Sriamporn S., Snijders P.J., Pientong C., et al. Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, northeast Thailand. Int. J. Gynecol. Cancer 16 (2006) 266-269
23. Thomas D.B., Qin Q., Kuypers J., et al. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. Am. J. Epidemiol. 153 (2001) 732-739
24. Chichareon S., Herrero R., Munoz N., et al. Risk factors for cervical cancer in Thailand: a case-control study. J. Natl. Cancer Inst. 90 (1998) 50-57
25. Guimaraes M.C., Goncalves M.A., Soares C.P., Bettini J.S., Duarte R.A., and Soares E.G. Immunohistochemical expression of p16INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions. J. Histochem. Cytochem. 53 (2005) 509-516
26. Bozzetti M., Nonnenmacher B., Mielzinska I.I., et al. Comparison between hybrid capture II and polymerase chain reaction results among women at low risk for cervical cancer. Ann. Epidemiol. 10 (2000) 466
27. Lorincz A.T. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J. Obstet. Gynaecol. Res. 22 (1996) 629-636
28. Cope J.U., Hildesheim A., Schiffman M.H., et al. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J. Clin. Microbiol. 35 (1997) 2262-2265
29. Smits H.L., Bollen L.J., Tjong A.H.S.P., et al. Intermethod variation in detection of human papillomavirus DNA in cervical smears. J. Clin. Microbiol. 33 (1995) 2631-2636
30. Lonky N.M., Felix J.C., Naidu Y.M., and Wolde-Tsadik G. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation. Obstet. Gynecol. 101 (2003) 481-489
31. Bibbo M., Klump W.J., DeCecco J., and Kovatich A.J. Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens. Acta Cytol. 46 (2002) 25-29
32. Saqi A., Pasha T.L., McGrath C.M., Yu G.H., Zhang P., and Gupta P. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagn. Cytopathol. 27 (2002) 365-370
33. Wang S.S., Trunk M., Schiffman M., et al. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1355-1360
34. Bose S., Evans H., Lantzy L., Scharre K., and Youssef E. p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear. Diagn. Cytopathol. 32 (2005) 21-24
35. Castle P.E., Wacholder S., Sherman M.E., et al. Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women. Cancer 95 (2002) 2145-2151
36. Yoshida T., Fukuda T., Sano T., Kanuma T., Owada N., and Nakajima T. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials. Cancer 102 (2004) 100-108
37. Nieh S., Chen S.F., Chu T.Y., et al. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol. Oncol. 97 (2005) 35-40
38. Negri G., Vittadello F., Romano F., et al. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch. 445 (2004) 616-620